Pancreatic Cancer Research

ResearcherJilin UniversityNo recent work listed

Qi Zhu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0001-8197-9059; OpenAlex author ID A5101803627. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 2 papers

Papers 3

  1. microRNA-382 suppresses the progression of pancreatic cancer through the PI3K/Akt signaling pathway by inhibition of Anxa3. Co-author DOI 10.1152/ajpgi.00322.2019↗
  2. Long noncoding RNA Linc00337 functions as an E2F1 co-activator and promotes cell proliferation in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s13046-020-01725-5↗
  3. eEF1A2 protein expression correlates with lymph node metastasis and decreased survival in pancreatic ductal adenocarcinoma. Last author DOI 10.5754/hge12869↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rongfeng Qu · 1 shared paper, 2020 · strength 0.16
  2. Xiaohui Wan · 1 shared paper, 2020 · strength 0.16
  3. Wenjie Zhang · 1 shared paper, 2020 · strength 0.11
  4. Huakai Wang · 1 shared paper, 2020 · strength 0.11
  5. Honggang Xiang · 1 shared paper, 2020 · strength 0.11
  6. Duanmin Hu · 1 shared paper, 2013 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.